Enfermedades gastrointestinales y hepáticas
Hospital POVISA
Vigo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital POVISA (2)
2022
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1